NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Report: Equity Indices Decline Amid Concerns Over AI-Led Disruption

On Tuesday, 1.5% decline was observed in the equity benchmark indices Sensex and Nifty, primarily driven by a sharp sell-off in IT shares.

The Nifty IT index has extended its losses for the fifth consecutive session, reaching a multi-month low and eroding 21% so far this month. The decline has been largely attributed to concerns over AI-led disruptions, particularly following the launch of Anthropic's new Claude AI security tool.

Global cues have been unsupportive, with Asian markets largely muted and US equities ending nearly 2% lower overnight. The decline followed remarks by US President Donald Trump warning countries against abandoning newly negotiated trade deals.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Sector-wise, IT and Realty emerged as the top laggards, falling nearly 5% and 3% respectively. On the other hand, Pharma, Healthcare, and Metal stocks managed to stay resilient, posting marginal gains of less than 0.5%.

Investors are advised to monitor the 25,250 zone, which coincides with the 200-day EMA, as a crucial level of support. A sustained hold near this level could trigger some short-covering bounce in the near term.

Investor Takeaway

Investors should be cautious of the IT sector's earnings outlook due to concerns over AI-led disruptions.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.